Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

67 results about "Treatment success" patented technology

Patient treatment and monitoring systems and methods

The invention provides apparatus and methods for home or other remote delivery of health care that gather subjective and objective measures of patient health and treatment, analyzing them (e.g., correlating them with one another and / or with norms) and reporting them to aid in on-going patient diagnosis and treatment (both on acute and chronic bases), as well as to aid physicians, nurses and other caregivers in decision support, monitoring treatment compliance, facilitating regulatory compliance, billing, and so forth. Thus, for example, in some aspects a health care delivery device comprising a medical treatment apparatus, such as a home hemodialysis or home peritoneal dialysis unit, that is coupled to a processor. The processor generates patient queries in connection with treatments rendered by the dialysis equipment (or other treatment apparatus). The queries are directed, at least in part, to subjective topics, such as the state of the patient's mental health and well being, quality of life, degrees of pain, views on success of therapy, and so forth. They are presented on an LCD screen or other output device coupled to the processor to elicit responses on a keyboard or other input device, also coupled to the processor.
Owner:FRESENIUS MEDICAL CARE HLDG INC

Sequence-based measures of immune response

The invention is directed to methods of measuring an immune response by comparing sequence-based clonotype frequency data from successively measured clonotype profiles. In particular, the invention includes immunotherapies of cancers, such as lymphomas, that include sensitive pre- and post-vaccination sequence-based measurements of changes in a patient's immune repertoire, thereby providing a sensitive measure of the likelihood of treatment success.
Owner:ADAPTIVE BIOTECH

Electrotherapy device for treating tachycardiac arrhythmias of a heart

An electrotherapy system, particularly an implantable heart stimulator, is configured as an electronic implant for electrical anti-tachycardia therapy of the heart, and includes at least one programmable therapy sequence (i.e. a sequence of several therapies that are delivered, one after the other, to treat a VT / VF episode). The implant has a therapy success memory for storing therapy success statistics for each therapy, as well as a therapy control unit that is configured to automatically undertake adaptation of the order of the therapies within a therapy sequence as a function of currently stored therapy success statistics.
Owner:BIOTRONIK SE & CO KG

Therapeutic success prediction for atrial fibrillation

Certain embodiments of the invention provide methods of assessing a patient's risk for atrial fibrillation (AF) recurrence after receiving treatment with an AF treatment modality, that include determining, from left atrium (LA) tissue image data of a patient, a level of a parameter that is positively proportional to an amount of unhealthy tissue in a wall of the LA of the patient; and outputting, to an output device, an indicator of a comparison between (i) the determined level and (ii) a first threshold level of the parameter, the first threshold level derived from LA tissue image data of at least one other patient, who experienced an AF recurrence after treatment with the AF treatment modality. In certain embodiments, levels of the parameter equal to or greater than the first threshold level are indicative of a significant risk of AF recurrence after treatment with the AF treatment modality.
Owner:UNIV OF UTAH RES FOUND

Devices and methods for assisting valve function, replacing venous valves, and predicting valve treatment success

Devices and methods for assisting valve function, replacing venous valves, and predicting valve treatment successes. In at least one embodiment of an endograft valve device of the present disclosure, the device comprises an endograft body configured for expansion from a collapsed configuration to an expanded configuration within a luminal organ and comprising a first portion having a proximal end defining a proximal end aperture and a distal end defining a distal end aperture, the first portion tapering toward the distal end so that the distal end aperture has a relatively smaller cross-sectional area than the proximal end aperture when the valve device is expanded, and a valve portion positioned at or near the distal end of the first portion, the valve portion configured to receive fluid flowing through the distal end aperture of the first portion.
Owner:3DT HLDG

Tooth arranging method in orthodontics

The invention discloses a tooth arranging method in orthodontics. By intelligent quantitative analyses, a reference scheme is provided for an orthodontic process, so that the scheme design process canbecome more convenient and fast, the orthodontic scheme is more accurate, the orthodontic treatment time is reduced, and the treatment success rate is improved.
Owner:上海牙典医疗器械有限公司

Novel cardiac valve implantation instrument with anchoring device

ActiveCN104055603AImprove the success rate of entryAchieving Elastic AdaptabilityStentsHeart valvesAutologous tissueTreatment success
The invention relates to a novel cardiac valve implantation instrument with an anchoring device. The novel cardiac valve implantation instrument comprises a cardiac valve prosthesis, at least two sets of anchoring needles and at least two sets of anchoring needle releasing devices detachably connected with the cardiac valve prosthesis. The far ends of the anchoring needles are in preset shapes, the anchoring needle releasing devices comprise conveying pipes, push rods and hollow guide rails, the guide rails are arranged in the conveying pipes in advance and can move towards the far ends of the conveying pipes, rigid sections are arranged at the far ends of the guide rails, the anchoring needles are arranged in the guide rails in advance in an extension state, the push rods are arranged in the conveying pipes and located at the near ends of the anchoring needles, the far ends of the anchoring needle releasing devices are in preset shapes, the far ends of the conveying pipes can be overall bent or partially bent, the guide rails and the anchoring needles can move towards the far ends of the conveying pipes under the action of external force, and the cardiac valve prosthesis is fixedly arranged between the autologous tissue and the anti-falling ends of the anchoring needles. The novel cardiac valve implantation instrument can achieve accurate locating and firm anchoring, and the treatment success rate is improved.
Owner:NINGBO JENSCARE BIOTECHNOLOGY CO LTD

Differential method for navigation electronic map, matching method and device

The invention discloses a differential method for navigation electronic map, a matching method and a device, wherein the matching method comprises steps of: carrying out first matching treatment on afirst navigation electronic map and a second navigation electronic map according to the names of reference substances of the first navigation electronic map and the second navigation electronic map; and using the reference substances with the same names as the reference substances of the first matching treatment success. By using the invention, the map encryption or the difference which is whollyshifted can be effectively solved, thus solving the problem of low difference processing accuracy caused by looking up two version data differences from geometry point of view.
Owner:NAVINFO

Heat treatment method for large high-speed steel cold-rolled work roll

The invention discloses a heat treatment method for a large high-speed steel cold-rolled work roll, and belongs to the technical field of heat treatment. The heat treatment method comprises pretreatment, preheat treatment and finish heat treatment. The preheat treatment comprises integral low-temperature preheat and continuous induction heating preheat. During continuous induction heating preheat, the temperature of the roll when the roll gets out of an induction coil is required to be 600-750 DEG C, the roll continues to move upwards, air cooling is conducted for 15-35 min after the roll gets out of the induction coil, and finish heat treatment is conducted. The heat treatment method is different from a conventional continuous induction quenching manner, the roll body continuous induction preheat treatment step is added on the basis of conventional integral preheat, and the heat treatment success rate of the large high-speed steel roll can be greatly increased. Meanwhile, cold treatment is added after first-time tempering of the roll is conducted, a roll body has hardness of 90 HSD or more after finish heat treatment of the high-speed steel cold-rolled work roll is conducted, and the technology requirement of a cold-rolled steel plate can be completely met.
Owner:SINOSTEEL XINGTAI MACHINERY & MILL ROLL

Molecular technologies for improved risk classification and therapy for acute lymphoblastic leukemia in children and adults

The present invention relates to methods for predicting the outcome of therapeutic intervention in cases of leukemia, especially acute lymphoblastic leukemia in children and adults. The present invention evaluates a gene expression profile and identifies prognostic genes of cancers, in particular leukemia, more particularly B-precursor acute lymphoblastic leukemia (ALL). The present invention provides a method of determining prognosis of leukemia, in particular, acute lymphoblastic leukemia, more particularly B-precursor ALL and predicting therapeutic outcome of a patient. The method comprises the steps of first establishing the threshold value of at least three prognostic genes of leukemia, preferably at least eight prognostic genes, or preferably, as many as 26 prognostic genes. Then, the amount of the prognostic gene(s) from a leukemia patient is determined. The amount of the prognostic gene present in that patient is compared with the established threshold value of the prognostic gene(s) which is indicative of therapeutic success or failure, whereby the prognostic outcome of the patient is determined / predicted.
Owner:STC UNM

Method to assess prognosis and to predict therapeutic success in cancer by determining hormone receptor expression levels

ActiveUS20120157542A1High quality determinationSmall amount requiredBiocideOrganic active ingredientsHormoneBiology
The present invention is related to a method of classifying a sample of a patient who suffers from or being at risk of developing cancer, said method comprising the steps of determining in said sample from said patient, on a non protein basis, the expression level of at least one gene encoding for a hormone receptor selected from the group comprising estrogen receptor, progesterone receptor and / or androgen receptor in said sample; comparing the one or more expression level(s) determined with one or more expression level(s) of one or more reference genes, and classifying the sample of said patient from the outcome of the comparison into one of at least two classifications.
Owner:WIRTZ

Nucleic acid molecules for reduction of papd5 or papd7 mRNA for treating hepatitis b infection

The present invention relates to a method for identifying a compound that prevents, ameliorates and / or inhibits a hepatitis B virus (HBV) infection, wherein a compound that reduces the expression and / or activity of PAP associated domain containing 5 (PAPD5) and / or PAP associated domain containing 7 (PAPD7) is identified as a compound that prevents, ameliorates and / or inhibits a HBV infection. The invention also provides for inhibitors of PAPD5 or PAPD7 for use in treating and / or preventing a HBV infection; as well as a combined preparation comprising an inhibitor of PAPD5 and an inhibitor of PAPD7 for simultaneous or sequential use in the treatment or prevention of a HBV infection. Also comprised in the present invention is a pharmaceutical composition for use in the treatment and / or prevention of a HBV infection, and a method for monitoring the therapeutic success during the treatment of a HBV infection.
Owner:F HOFFMANN LA ROCHE & CO AG

Oral soft tissue detection device and oral soft tissue detection method based on optical Doppler imaging

The invention provides an oral soft tissue detection device and an oral soft tissue detection method based on optical Doppler imaging, wherein an optical fiber type Michelson interferometer hardware system built by a frequency sweep laser with a central wavelength of 1310 nm and a phase resolution algorithm software system are adopted to achieve the imaging detection of a biological tissue three-dimensional structure and a microvascular blood flow velocity. The specific implementation process comprises that the backscattered light of an interferometer sample arm and the backscattered light a reference arm generate an interference signal at a coupler; a photoelectric balance detector receives the interference signal; a 12-bit data acquisition card performs data acquisition; a phase resolution algorithm performs information processing; image reconstruction is carried out to obtain a sample structure image and a microvascular blood flow velocity result; and the information is applied to clinical diagnosis and later treatment process detection on oral diseases by a doctor, so that the influence process of oral soft tissue diseases on the three-dimensional structure and the microvascular blood flow rate of the oral soft tissue diseases can be monitored so as to substantially improve the treatment success rate of the oral diseases.
Owner:NANCHANG HANGKONG UNIVERSITY

Medical guide system for emergency treatment call information input and intelligent graded diagnosis and treatment

The invention discloses a medical guide system for emergency treatment call information input and intelligent graded diagnosis and treatment. The medical guide system comprises a user terminal, a cloud server, a disease analysis module, a doctor-seeing suggestion module and an emergency treatment triage and guide module, wherein the user terminal is loaded on a user mobile terminal through an APPor a WeChat program, a user registers a login account and can perform operations such as data filling, patient symptom reporting and the like on an operation interface, and the cloud server realizes data transmission among the user terminal, the disease analysis module, the doctor-seeing suggestion module and the emergency treatment triage and guide module through a network. According to the medical guide system with the intelligent grading diagnosis and treatment function, the doctor-seeing time of a patient can be effectively advanced so as to avoid the optimal treatment time from being missed, a treatment scheme can be provided according to patient symptom analysis so as to effectively save medical resources and improve the diagnosis and treatment efficiency and the treatment success rate, and non-emergency patients can be left in primary hospitals for graded diagnosis and treatment so as to meet national medical policies.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV

Methods and Models for Determining Likelihood of Cancer Drug Treatment Success Utilizing Predictor Biomarkers, and Methods of Diagnosing and Treating Cancer Using the Biomarkers

A method of identifying one or more biomarkers associated with one or more drugs effective to stop or repress proliferation of cancer cells, and a system for predicting effectiveness of the same. The method includes statistically analyzing (i) a first dataset of expression levels of proteins or glycoproteins in the cancer cells and (ii) a second dataset of responses of the cancer cells to drugs to identify at least one biomarker associated with effective repression of the cancer cells, and correlating or associating at least one protein or glycoprotein biomarker with a response of the cells to at least one of the drugs effective to stop or repress the proliferation of the cancer cells. The protein and / or glycoprotein expression level datasets may be generated experimentally or taken from published information. The method advantageously determines and / or predicts drug sensitivity of various cancer cells using protein and glycoprotein biomarkers.
Owner:MACHER BRUCE +3

3D (three-dimensional) model and VR (virtual reality) technology-based coronary artery disease simulating diagnosis and treatment system

The invention discloses a 3D model and VR technology-based coronary artery disease simulating diagnosis and treatment system and relates to the technical field of virtual reality. The 3D model and VRtechnology-based coronary artery disease simulating diagnosis and treatment system solves the problems of operation difficulty in coronary artery disease diagnosis and treatment due to individual difference and complicated and changeable conditions of patients, and obstacles brought by coronary artery disease complications to coronary artery disease diagnosis and treatment. The 3D model and VR technology-based coronary artery disease simulating diagnosis and treatment system is technically characterized by comprising a modeling system and a VR operation system, wherein the modeling system comprises a data collecting unit, a 3D modeling unit and a lesion simulating unit, the 3D modeling unit and the data collecting unit are connected, and the lesion simulating unit is connected with the data collecting unit, the 3D modeling unit and the VR operation system; the VR operation system comprises a complication setting unit, a visual feedback unit and a tactile feedback unit. The 3D model andVR technology-based coronary artery disease simulating diagnosis and treatment system can provide a coronary artery disease patient preoperative drilling system for interventional physicians, achievepreoperative training for the interventional physicians and improve the coronary artery disease diagnosis and treatment success rate of the interventional physicians.
Owner:JIANGXI PROVINCIAL PEOPLES HOSPITAL

Clinical assessment of an intravenous catheter site

A system and method for assessing an intravenous catheter site is described in embodiments herein. An application accessible on a mobile device may be used to take calibrated photographs of an intravenous catheter site. The resulting calibrated image may be compared to previously taken calibrated images to determine a complication. Success of treatments to the complication may be tracked and the patient's electronic medical record may be updated.
Owner:NEXUS MEDICAL LLC

Model and system for predicting severe new coronal pneumonia as well as establishment method and prediction method thereof

ActiveCN113409947AHelp identifyImprove the success rate of diagnosis and treatmentHealth-index calculationEpidemiological alert systemsDiseaseCD16
The invention relates to a model and a system for predicting severe new coronal pneumonia as well as an establishment method and a prediction method of the model and the system, and the prediction model is a progression risk score calculation model obtained according to lung diseases, age, immune globulin M (IgM), CD16 + / CD56 + NK cells and aspartate transaminase (AST) of a patient with new coronal pneumonia so as to predict the risk of progressing from mild / ordinary type to severe new coronal pneumonia. According to the invention, light / ordinary patients with high development risk can be identified, and the diagnosis and treatment success rate of critical patients can be improved.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV

Automated measurement of brain injury indices using brain CT images, injury data, and machine learning

A decision-support system and computer implemented method automatically measures the midline shift in a patient's brain using Computed Tomography (CT) images. The decision-support system and computer implemented method applies machine learning methods to features extracted from multiple sources, including midline shift, blood amount, texture pattern and other injury data, to provide a physician an estimate of intracranial pressure (ICP) levels. A hierarchical segmentation method, based on Gaussian Mixture Model (GMM), is used. In this approach, first an Magnetic Resonance Image (MRI) ventricle template, as prior knowledge, is used to estimate the region for each ventricle. Then, by matching the ventricle shape in CT images to the MRI ventricle template set, the corresponding MRI slice is selected. From the shape matching result, the feature points for midline estimation in CT slices, such as the center edge points of the lateral ventricles, are detected. The amount of shift, along with other information such as brain tissue texture features, volume of blood accumulated in the brain, patient demographics, injury information, and features extracted from physiological signals, are used to train a machine learning method to predict a variety of important clinical factors, such as intracranial pressure (ICP), likelihood of success a particular treatment, and the need and / or dosage of particular drugs.
Owner:VIRGINIA COMMONWEALTH UNIV

Porous metal rod

The invention relates to a porous metal rod for medical implanting used for treating early-stage and middle-stage femoral head necrosis. The porous metal rod comprises two parts, wherein one part is a round-rod-shaped part, the other part connected with the round-rod-shaped part is a threaded part, threads are arranged on the outer part of the threaded part, the outer diameter of the threads is greater than that of the round rod shape, a notch is formed in the end face of the threaded part, the outer diameter of one section, close to the round rod shape, of the threaded part is gradually reduced towards the round-rod-shaped part, so that the stress at the joint of the threaded part and the round-rod-shaped part is reduced, thus the fracture failure of the porous metal rod can be avoided, and finally, the treatment success rate is improved.
Owner:CHONGQING RUNZE PHARM CO LTD

Construction method of subway shield tunnel crossing prestressed anchor cable

PendingCN110374617ASimple processMature technology of rotary grouting pile reinforcementTunnelsBulkheads/pilesPre stressTreatment success
The invention relates to the technical field of tunnel construction, in particular to a construction method of a subway shield tunnel crossing a prestressed anchor cable. The construction method comprises the following steps that construction preparation is made before a shield machine crosses the anchor cable, and a bin opening point is preset after the preparation is completed; then a jet grouting pile is used for reinforcement in an anchor cable area; a reinforced soil body for rotary jet grouting reinforcement is tested, after reinforcement meets requirements, shield tunneling is carried out, anchor cable crossing construction is carried out, and shield tunneling parameters are controlled and analyzed in the construction process; according to the excavation parameters, the bin openingpoint opening operation is reasonably selected, the anchor cable wound on a cutter head is removed, or a cutter is replaced; and after the bin opening operation is completed, shield tunneling construction is restored, and finally the shield machine crosses the anchor cable. The construction method is simple in process; the jet grouting pile reinforcement technology and the shield bin opening technology are relatively mature, the implementation efficiency is high, and the construction safety is ensured; and the basis and construction experience are provided for the subsequent process that a shield crosses the anchor cable, the anchor cable treatment success rate is improved, and the construction difficulty is reduced.
Owner:CHINA CONSTR FOURTH ENG DIV

Blood pressure and blood sugar monitoring system

The invention provides a blood pressure and blood sugar monitoring system. The system comprises a blood pressure measuring module, a blood sugar measuring module and a health management center, wherein the health management center comprises a health assessment module, an operation management module and a database; the blood pressure measuring module and the blood sugar measuring module are connected with the health management center through an Internet of Things card; the operation management module is connected with the health assessment module and the database; the blood pressure measuring module is used for measuring blood pressure of the human body and transmitting the blood pressure to the operation management module; the blood sugar measuring module is used for measuring blood sugarof the human body and transmitting the blood sugar to the operation management module; the health assessment module is used for calling measurement data to assess the health condition of the human body; the database is used for storing the measurement data, an assessment result and diagnosis and treatment case data transmitted by the operation management module; and the operation management moduleis used for comparing the measurement data and the assessment result with the diagnosis and treatment case data in the database, finding out a proximate diagnosis and treatment success case, and extracting a treatment scheme of the diagnosis and treatment success case to serve as an auxiliary reference for diagnosis and treatment.
Owner:北京凤凰医联企业管理有限公司

Puncture instrument for positioning center of oval foramen of cranial base

The invention provides a puncture instrument device for positioning the center of an oval foramen of a cranial base. The puncture instrument comprises a main frame, a sliding block, sliding block threaded holes, a sliding groove, fixing bolts, an adjustable fixing rod, an angle gauge, a fixing threaded ring, a measurement rod, a protractor, a protractor inserting groove and a head support. The puncture instrument for positioning the center of the oval foramen of the cranial base is made of high-quality acrylic materials, has remarkable advantages, can be used in a CT scanner, and does not affect diagnosis or treatment; meanwhile, a target spot can be clearly positioned through the measurement rod and the angle gauge, so that an objective and digital basis is provided for the positioning process, puncturing blindness is avoided, puncturing precision is improved, and the treatment success rate is increased, and the occurrence rate of complications is reduced; the puncture instrument is simple in structure, convenient to use, practical, high in work efficiency, capable of overcoming the detect of a traditional positioning method, and worth clinically popularizing and applying.
Owner:GUANGXI MEDICAL UNIVERSITY

A Novel Heart Valve Implantation Device with Anchoring Device

ActiveCN104055603BImprove the success rate of entryAchieving Elastic AdaptabilityStentsHeart valvesAutologous tissueTreatment success
The invention relates to a novel cardiac valve implantation instrument with an anchoring device. The novel cardiac valve implantation instrument comprises a cardiac valve prosthesis, at least two sets of anchoring needles and at least two sets of anchoring needle releasing devices detachably connected with the cardiac valve prosthesis. The far ends of the anchoring needles are in preset shapes, the anchoring needle releasing devices comprise conveying pipes, push rods and hollow guide rails, the guide rails are arranged in the conveying pipes in advance and can move towards the far ends of the conveying pipes, rigid sections are arranged at the far ends of the guide rails, the anchoring needles are arranged in the guide rails in advance in an extension state, the push rods are arranged in the conveying pipes and located at the near ends of the anchoring needles, the far ends of the anchoring needle releasing devices are in preset shapes, the far ends of the conveying pipes can be overall bent or partially bent, the guide rails and the anchoring needles can move towards the far ends of the conveying pipes under the action of external force, and the cardiac valve prosthesis is fixedly arranged between the autologous tissue and the anti-falling ends of the anchoring needles. The novel cardiac valve implantation instrument can achieve accurate locating and firm anchoring, and the treatment success rate is improved.
Owner:NINGBO JENSCARE BIOTECHNOLOGY CO LTD

Cranial periphery position finder

The invention discloses a cranial periphery position finder which comprises a puncture point constraining plane, a rectangular wire and a puncture wire. A rotary seat and puncture point positioning balls are arranged on the puncture point constraining plane; guide grooves which are perforated through ball centers of the puncture point positioning balls are formed in the puncture point positioning balls; a mounting rod is movably mounted on the rotary seat, a mounting block is movably arranged on the top of the mounting rod, a sliding rod is movably mounted on the mounting block and is perpendicular to the mounting rod, and an end of the sliding rod is connected with one end of a sagittal position reference surface; a rotary cushion surface is arranged at the other end of the sagittal position reference surface, the rotary cushion surface and the sagittal position reference surface are coplanar, and a bearing tube is arranged on the rotary cushion surface; a wide edge of the rectangular wire penetrates the bearing tube, a wire tube is arranged at a long edge of the rectangular wire, and the puncture wire penetrates the wire tube. The cranial periphery position finder has the advantages that the cranial periphery position finder is simple in structure, convenient to operate and high in target hit rate, the patient treatment time can be shortened, accurate puncture can be guaranteed, the treatment success rate can be increased, and popularization and application of the cranial periphery position finder primary hospitals can be facilitated.
Owner:周军

Method for synthesizing pRNA-3WJ-siLNAgapmer-aptamer

The invention discloses a method for synthesizing a nano-targeting gene pRNA-3WJ-siLNAgapmer-aptamer. Firstly, pRNA is packaged with a bacteriophage Phi29 with a 'three-way junction' structural domain3WJ, and pRNA-3WJ is taken as a gene vector; then small interfering LNA is in chimerism in one end of the 3WJ; an RNA aptamer of a CD40 molecule capable of being in targeted combination with a CD40 cell is in chimerism in the other end of the 3WJ to synthesize the nano-targeting gene pRNA-3WJ-siLNAgapmer-aptamer, wherein locked nucleic acid siLNAgapmer corresponds to a tuberculosis gene Mce4, andthe aptamer corresponds to CD40. The nano-targeting gene pRNA-3WJ-siLNAgapmer-aptamer can be targeted into a lesion, effectively inhibit the growth and survival of mycobacterium tuberculosis, and hasa high treatment success rate.
Owner:GENERAL HOSPITAL OF NINGXIA MEDICAL UNIV

Compound medicine for treating diabetes

The present invention provides a compound drug for treating diabetes, the compound drug is prepared by berberine intestinal controlled-release microcapsules and a common western medicine for treating diabetes, 10 to 90 percent of the daily maximum dose of the berberine which is the active ingredient in the berberine intestinal controlled-release microcapsules and 90 to 10 percent of the daily maximum dose of the active ingredient of one common western medicine which is chosen randomly for treating diabetes are used for compound preparation. The berberine intestinal controlled-release microcapsules used in the compound drug of the present invention are the effective drug for treating diabetes, and the microcapsule diameter is 35 to 5000 Mum. The present invention provides the compound drug for treating diabetes, which mainly makes use of the complementary synergistic effect of the main drugs to achieve the purpose of reducing the blood glucose. The compound drug of the present invention for treating diabetes has high treatment success rate, less toxicity, fewer side effects and lower dose; furthermore, the present invention can effectively improve the compliance of the medication of the patients, so as to enhance the effect of reducing blood glucose of the drugs treating diabetes.
Owner:左仁杰 +4

Wulong bone pain plaster

The invention provides a Wulong bone pain plaster. The Wulong bone pain plaster is prepared from raw materials by weight as follows: one white-dappled snake, 25 g of cassia twigs, 35 g of frankincense, 20 g of crude Sichuan aconite roots, 20 g of raw kusnezoff monkshood roots, 45 g of notopterygium roots, 25 g of radix angelicae pubescentis, 35 g of cortex eucommiae, 50 g of radix clematidis, 75 gof caulis spatholobi, 50 g of common clubmoss herbs, 35 g of garden balsam stems, 8 g of semen momordicae, 7 g of raw semen strychni, 25 g of common bletilla tuber, 35 g of dragon's blood, 45 g of rhizoma dioscoreae nipponicae, 50 g of radix saposhnikoviae, 10 g of borneol, 20 g of camphor, 2,000 g of sesame oil and 1,000 g of yellow lead. The Wulong bone pain plaster is obtained by mixing and blending traditional Chinese medicinal materials including the white-dappled snake, the notopterygium roots, the raw semen strychni and the like in a specific proportion, has good curative effects on hyperostosis, cervical spondylosis, waist and leg pain, lumbar disc herniation, knee arthritis, rheumatic bone pain, arthritis, scapulohumeral periarthritis and sciatica and has the treatment success rate high to 98%; and the plaster is prepared from pure natural traditional Chinese medicinal materials, has the algetic rate of 1 / 10,000 and is safe to use and good in curative effect.
Owner:王凯
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products